Quanta™ Dialysis System | Patient Care Continuity | Supply Chain Stability

Quanta™ — Simply Smarter

Experience greater control with the first and only FDA-cleared dialysis machine offering three modalities, all in one machine.

Triple The Functionality, Triple the Benefits to Patient Care

Discover the unmatched versatility of the Quanta Dialysis System. It enables dynamic, on-the-fly adjustments between therapy flow rates and on-demand dialysate fluid generation, improving mobility and prescription flexibility across care settings.

IHD

Intermittent Hemodialysis

Delivers a high dialysate flow rate of 500 mL.

<4 HOURS

SLED

Sustained Low Efficiency Dialysis

Delivers longer, slower therapies at dialysate flow rates of 100, 200 and 300mL/min.

<12 HOURS

CRRT¹

CVVHD or SCUF

Eliminates need for bagged dialysate changes, saving time and money.

UP TO 24 HOURS

Easy to Train

Simplify training, enhance patient focus.

The Quanta Dialysis System stands out not only for its clinical versatility but also for its remarkable ease of training. By simplifying the learning process, your team can dedicate more time to direct patient care and less to lengthy onboarding procedures.

Rapid Training Capability
Train staff in as little as 4.5 hours, ensuring they are quickly equipped to deliver top-notch care.²

High Success Rate
Achieves a 97% success rate among healthcare professionals with minimal training, demonstrating the system’s intuitive design and effectiveness.³

Unified Training Approach
One device supports all hemodialysis therapies, reducing the complexity and variety of training needed across different systems.

Easy to Maintain

Minimize upkeep, maximize care.

The Quanta Dialysis System is designed not only for efficiency but also for exceptional ease of maintenance. By reducing the complexity and time required for upkeep, your staff can concentrate more on patient care and less on device management.

No Bagged Dialysate Changes
Eliminates frequent bagged dialysate changes, saving valuable time and resources over each shift.

Weekly Hot Rinse
Requires just a single weekly hot rinse, freeing up to 14 hours per week per device that would otherwise be spent on daily cleaning.⁴

Designed for Simplicity
Streamlined setup and take-down that optimizes staff time and effort, critical in environments facing high turnover and staffing challenges.

Insourcing the Quanta Dialysis System into our ICU, and building a de novo CRRT program has resulted in both timely initiation of renal replacement therapy and efficient volume status optimization.

Despite being a new program, initial observations highlight improved time to successful extubation and reduced length of stay in the ICU.

Dr. Prashanth Kumar

Nephrologist

Victorville, CA

The Quanta device is in most respects a "standard" hemodialysis machine, using its own RO water for dialysate at a flow of 500cc/min BUT in the same treatment may be converted to CRRT mode by reducing dialysis flow rates to as low as 50cc/min.

In facilities not presently employing CRRT, Quanta may also have advantages over standard Prisma or NxStage.

Dr. Richard Barnett

Director of Renal Critical Care

Long Island, NY

Quanta’s sustained low-efficiency dialysis, in my opinion, has allowed us to provide the standard of ICU-level renal care this region has desperately needed.

The ability to safely dialyze, in the ICU, what we would consider the sickest patients in the hospital truly gives us the opportunity to give every patient a fighting chance at survival.

Dr. Opeyemi Oladele

Nephrologist

Victorville, CA

Our team is highly satisfied with the Quanta machine in terms of ease of use and performance during routine use.

The interface is intuitive and user-friendly, making it easy to operate even in high-pressure situations. The machine's reliability and efficiency have greatly improved our ability to provide top-notch care to our patients.

Ruben Orozco

ICU Manager

Apple Valley, CA

Book a personalized exploration session to discover how Quanta ensures patient care continuity and supply chain stability, overcoming operational inefficiencies while delivering customized dialysis treatment in critical settings.

FDA 510(k) K222067 for CVVHD and SCUF: two modalities of CRRT.
Harasemiw O., et al. Human factors testing of the Quanta SC+ hemodialysis system: An innovative system for home and clinic use. Hemodialysis Int. 2019; 23:306-313.
Compton K. et al., Human Factors Testing of the Quanta SC+ Haemodialysis System: Demonstrating Ease of Use in Healthcare Practitioners and Patients with Minimal Upfront Training. Poster presented at EDTA Conference 2020 Jun.
Quanta Dialysis System User Manual

SM-293 v 1.0